Table 1. Baseline patient characteristics.
|
Total |
CRT |
CT |
|
|||
---|---|---|---|---|---|---|---|
Characteristic | Number | % | Number | % | Number | % | P-value* |
Median age, years (63.0) |
|
|
|
|
|
|
0.0501 |
<63.0 | 45 | 49.5 | 32 | 56.1 | 13 | 38.2 | |
⩾63.0 |
46 |
50.5 |
25 |
43.9 |
21 |
61.8 |
|
Gender |
|
|
|
|
|
|
1 |
Male | 53 | 58.2 | 33 | 57.9 | 20 | 58.8 | |
Female |
38 |
41.8 |
24 |
42.1 |
14 |
41.2 |
|
PS |
|
|
|
|
|
|
0.2681 |
0 | 26 | 28.6 | 17 | 29.8 | 9 | 26.5 | |
1 | 63 | 69.2 | 40 | 70.2 | 23 | 67.6 | |
2 |
2 |
2.2 |
0 |
0.0 |
2 |
5.9 |
|
Median tumour size, mm (37.4) |
|
|
|
|
|
|
0.3862 |
<37.4 mm | 44 | 48.4 | 14 | 41.2 | 30 | 52.6 | |
⩾37.4 mm |
47 |
51.6 |
20 |
58.8 |
27 |
47.4 |
|
Lymph node metastasis |
|
|
|
|
|
|
1 |
Negative | 64 | 70.3 | 40 | 70.2 | 24 | 70.6 | |
Positive |
27 |
29.7 |
17 |
29.8 |
10 |
29.4 |
|
Location of the tumour |
|
|
|
|
|
|
0.0501 |
Head of pancreas |
43 |
47.3 |
22 |
38.6 |
21 |
61.8 |
|
Body or tail of pancreas |
48 |
52.7 |
35 |
61.4 |
13 |
38.2 |
|
CA19-9 |
|
|
|
|
|
|
|
<1000 U ml−1 | 62 | 68.1 | 39 | 68.4 | 23 | 67.6 | 1 |
⩾1000 U ml−1 | 29 | 31.9 | 18 | 31.6 | 11 | 32.4 |
Abbreviations: CRT=chemoradiotherapy; CT=chemotherapy; PS=Eastern Cooperative Oncology Group Performance Status.
*P-value: Fisher's exact test (two sided).